First-Line Odronextamab (Odro) Plus Chemotherapy (Chop) in Diffuse Large B-Cell Lymphoma (Dlbcl): Olympia-3 Part 1b Results

Authors

• Matthew Matasar
• Thomas A. Jandl
• Rita Assi
• Philip Kuriakose, Henry Ford HealthFollow
• Chait Iragavarapu
• Thomas Illmer
• Neta Goldschmidt
• Abraham Avigdor
• Youngwoo Jeon
• Shin Ong
• Costas K. Yannakou
• Hanlon Sia
• Ho Jin Shin
• Lily Wong
• Sonia Gonzalez de Villambrosia
• Ahlam N. Kori
• Ciel De Vriendt
• Alice Cao
• Nazia Iqbal
• Jean-Marie Michot

Recommended Citation

Matasar M, Jandl TA, Assi R, Kuriakose P, Iragavarapu C, Illmer T, Goldschmidt N, Avigdor A, Jeon Y, Ong S, Yannakou CK, Sia H, Shin H, Wong L, Gonzalez de Villambrosia S, Kori AN, De Vriendt C, Cao A, Iqbal N, Michot J. First-Line Odronextamab (Odro) Plus Chemotherapy (Chop) in Diffuse Large B-Cell Lymphoma (Dlbcl): Olympia-3 Part 1b Results. J Clin Oncol 2026; 44(16_SUPPL):1.

Document Type

Conference Proceeding

Publication Date

5-27-2026

Publication Title

J Clin Oncol

Keywords

Oncology

Volume

44

Issue

16_SUPPL

First Page

1